144Filing Date: Aug 3, 2026
Dexcom (DXCM)
Insider Proposed Sale Notice
View SEC Filing
ACC: 0001969223-26-000825
Sale Plan
FOLETTA MARK G
Director·Dexcom
Proposed
CommonNASDAQ
Shares2.00K
Est. DateAug 3
Market Value$170.6K
BrokerUBS Financial Services, Inc.
AcquisitionVested RSUs · Issuer
Acquired DateMay 31, 2019
Amount Acquired2.00K
10b5-1 Plan Adoption03/13/2026
% Outstanding0.0005%
10b5-1
Exercise / Payment Details
Paid: May 31, 2019Method: N/A
Sales Past 3 Months Total $456.5K · 6.00K sh. expand_more
Jul
31
$160.0K
2.00K sh.
Jun
15
$296.5K
4.00K sh.
Signature & Compliance expand_more
Notice DateAug 3, 2026
10b5-1 Plan Adoption03/13/2026
Signature /s/ UBS Financial Services Inc, as attorney-in-fact for Mark Foletta
Issuer Info expand_more
CompanyDEXCOM INC
CIK0001093557
SEC File No.000-51222
Phone8582000200
Address6340 SEQUENCE DRIVE, SAN DIEGO, CA 92121